{"doc_id": "si-2020-0053-reg-1", "parent_doc_id": "si-2020-0053", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 53 of 2020", "title": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are", "year": 2020, "heading": "1. These Regulations may be cited as", "text_raw": "1. These Regulations may be cited as \n\nthe \n\nInfectious Diseases \n\n(Amendment) Regulations 2020.", "text_norm": "1 regulation may cited infectious disease (amendment) regulation 2020", "start_char": 415, "end_char": 514, "source_path": "downloads\\2020\\2020_0052.pdf", "extraction_method": "pdfminer", "checksum": "sha256:574aa40ab33f0e0cf695a6e57e8d9e4dd6916f4c1be730c0561708a21c1b93bf", "cross_refs": []}
{"doc_id": "si-2020-0053-reg-2", "parent_doc_id": "si-2020-0053", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 53 of 2020", "title": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are", "year": 2020, "heading": "In these Regulations, “Regulations of 2007” means the Infectious", "text_raw": "2. \n\nIn these Regulations, “Regulations of 2007” means the Infectious \n\nDiseases (Amendment) Regulations 2007 (S.I. No. 559 of 2007).", "text_norm": "2 regulation regulation 2007 mean infectious disease (amendment) regulation 2007 (s.i no 559 2007)", "start_char": 514, "end_char": 650, "source_path": "downloads\\2020\\2020_0052.pdf", "extraction_method": "pdfminer", "checksum": "sha256:574aa40ab33f0e0cf695a6e57e8d9e4dd6916f4c1be730c0561708a21c1b93bf", "cross_refs": []}
{"doc_id": "si-2020-0053-reg-3", "parent_doc_id": "si-2020-0053", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 53 of 2020", "title": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are", "year": 2020, "heading": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are", "text_raw": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are \n\namended - \n\n(a) \n\n(b) \n\n(c) \n\nin Regulation 8 (amended by Regulation 4(3) of the Regulations \nof 2007) by the insertion before “diphtheria” of “Covid-19,”, \n\nin Regulation 14(1)(b) (amended by Regulation 4(6) of the \nRegulations of 2007) by the insertion before “diphtheria” of \n“Covid-19,”, \n\nin Regulation 15(2)(a) (amended by Regulation 4(7) of the \nRegulations of 2007) by the insertion before “diphtheria” of \n“Covid-19,”, and \n\n(d) by the substitution of the following Schedule for the Schedule \n(amended by Regulation 2(b) of the Infectious Diseases \n(Amendment) Regulations 2018 (S.I. No. 567 of 2018)) to those \nRegulations: \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 28th February, 2020. \n\n \n \n \n \n \n \n \n \n \n \n\f[53] 3 \n\n“SCHEDULE \n\nDiseases specified to be infectious diseases and their respective causative \npathogens \n\nDisease \n\nCausative Pathogen \n\nAcute anterior poliomyelitis \n\nPolio virus \n\nAno-genital warts \n\nHuman papilloma virus \n\nAnthrax \n\nBacillus anthracis \n\nBacillus cereus food-borne \n\nBacillus cereus \n\ninfection/intoxication \n\nBacterial meningitis (not otherwise \n\nspecified) \n\nBotulism \n\nClostridium botulinum \n\nBrucellosis \n\nBrucella species \n\nCampylobacter infection \n\nCampylobacter species \n\nCarbapenemase producing \n\nEnterobacteriaceae \n\nenterobacteriaceae, infection or \n\ncolonisation \n\nChancroid \n\nHaemophilus ducreyi \n\n \n \n \n \n\f4 [53] \n\nChickenpox - hospitalised cases \n\nVaricella-zoster virus \n\nChikungunya disease \n\nChikungunya virus \n\nChlamydia trachomatis infection \n\nChlamydia trachomatis \n\n(genital) \n\nCholera \n\nVibrio cholerae \n\nClostridium difficile infection \n\nClostridium difficile \n\nClostridium perfringens (type A) food-\n\nClostridium perfringens \n\nborne disease \n\nCovid-19 \n\nSARS-CoV-2 \n\nCreutzfeldt Jakob disease \n\nvariant Creutzfeldt Jakob disease \n\nCryptosporidiosis \n\nCryptosporidium parvum, hominis \n\nCytomegalovirus infection (congenital) Cytomegalovirus \n\nDengue Fever \n\nDengue Virus \n\nDiphtheria \n\nCorynebacterium diphtheriae or \n\nulcerans (toxin producing) \n\nEchinococcosis \n\nEchinococcus species \n\n \n \n \n\f[53] 5 \n\nEnterococcal bacteraemia \n\nEnterococcus species (blood) \n\nEscherichia coli infection (invasive) \n\nEscherichia coli (blood, CSF) \n\nGiardiasis \n\nGiardia lamblia \n\nGonorrhoea \n\nNeisseria gonorrhoeae \n\nGranuloma inguinale \n\nKlebsiella granulomatis \n\nHaemophilus influenzae disease \n\nHaemophilus influenzae (blood, CSF \n\n(invasive) \n\nor other normally sterile site) \n\nHepatitis A (acute) infection \n\nHepatitis A virus \n\nHepatitis B (acute and chronic) \n\nHepatitis B virus \n\ninfection \n\nHepatitis C infection \n\nHepatitis C virus \n\nHepatitis E Infection \n\nHepatitis E virus \n\nHerpes simplex (genital) \n\nHerpes simplex virus \n\nHerpes simplex (neonatal) \n\nHerpes simplex virus \n\nHuman immunodeficiency virus \n\nHuman immunodeficiency virus \n\ninfection \n\nInfluenza \n\nInfluenza A and B virus \n\n \n\f6 [53] \n\nKlebsiella pneumoniae infection \n\nKlebsiella pneumoniae (blood or \n\n(invasive) \n\nCSF) \n\nLegionellosis \n\nLegionella species \n\nLeprosy \n\nMycobacterium leprae \n\nLeptospirosis \n\nLeptospira species \n\nListeriosis \n\nListeria monocytogenes \n\nLyme disease (neuroborreliosis) \n\nBorrelia burgdorferi \n\nLymphogranuloma venereum \n\nChlamydia trachomatis \n\nMalaria \n\nPlasmodium falciparum, vivax, \n\nknowlesi, ovale, malariae \n\nmcr-positive Enterobacteriaceae \n\nEnterobacteriaceae \n\ninfection or colonisation \n\nMeasles \n\nMeasles virus \n\nMeningococcal disease \n\nNeisseria meningitidis \n\nMumps \n\nMumps virus \n\nNon-specific urethritis \n\nNovel or Rare Antimicrobial-resistant \n\n \n \n \n\f[53] 7 \n\nOrganism (NRAO) \n\nNoroviral infection \n\nNorovirus \n\nParatyphoid \n\nSalmonella Paratyphi \n\nPertussis \n\nPlague \n\nBordetella pertussis \n\nYersinia pestis \n\nPseudomonas aeruginosa infection \n\nPseudomonas aeruginosa (blood or \n\n(invasive) \n\nCSF) \n\nQ Fever \n\nRabies \n\nCoxiella burnetii \n\nRabies virus \n\nRespiratory syncytial virus infection \n\nRespiratory syncytial virus \n\nRotavirus infection \n\nRotavirus \n\nRubella \n\nRubella virus \n\nSalmonellosis \n\nSalmonella spp other than S. Typhi \n\nand S. Paratyphi \n\nSevere Acute Respiratory Syndrome \n\nSARS-associated coronavirus \n\n(SARS) \n\nShigellosis \n\nShigella species \n\n \n\f8 [53] \n\nSmallpox \n\nVariola virus \n\nStaphylococcal food poisoning \n\nEnterotoxigenic Staphylococcus \n\naureus \n\nStaphylococcus aureus bacteraemia \n\nStaphylococcus aureus (blood) \n\nStreptococcus group A infection \n\nStreptococcus pyogenes (blood, CSF \n\n(invasive) \n\nor other normally sterile site) \n\nStreptococcus group B infection \n\nStreptoccus agalactiae (blood, CSF, \n\n(invasive) \n\nor other normally sterile site) \n\nStreptococcus pneumoniae infection \n\nStreptococcus pneumoniae (blood, \n\n(invasive) \n\nCSF or other normally sterile site) \n\nSyphilis \n\nTetanus \n\nTreponema pallidum \n\nClostridium tetani \n\nToxoplasmosis \n\nToxoplasma gondii \n\nTrichinosis \n\nTrichinella species \n\nTrichomoniasis \n\nTrichomonas vaginalis \n\nTuberculosis \n\nMycobacterium tuberculosis \n\ncomplex \n\nTularemia \n\nFrancisella tularensis \n\n \n\f[53] 9 \n\nTyphoid \n\nTyphus \n\nSalmonella Typhi \n\nRickettsia prowazekii \n\nVerotoxigenic Escherichia coli \n\nVerotoxin producing Escherichia coli \n\ninfection \n\nViral encephalitis \n\nViral haemorrhagic fevers \n\nViral meningitis \n\nWest Nile fever \n\nWest Nile virus \n\nYellow fever \n\nYellow fever virus \n\nYersiniosis \n\nYersinia enterocolitica, Yersinia \n\npseudotuberculosis \n\nZika virus infection \n\nZika virus\". \n\n \n \n \n \n \n \n\f10 [53] \n\nGIVEN under the Official Seal of the \nMinister for Health, \n20 February, 2020. \n\nSIMON HARRIS, \n\nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[53] 11", "text_norm": "3 infectious disease regulation 1981 (s.i no 390 1981) amended - (a) (b) (c) regulation 8 (amended regulation 4(3) regulation 2007) insertion diphtheria covid-19 regulation 14(1)(b) (amended regulation 4(6) regulation 2007) insertion diphtheria covid-19 regulation 15(2)(a) (amended regulation 4(7) regulation 2007) insertion diphtheria covid-19 (d) substitution following schedule schedule (amended regulation 2(b) infectious disease (amendment) regulation 2018 (s.i no 567 2018)) regulation notice making statutory instrument published iris oifigiuil 28th february 2020 53 3 schedule disease specified infectious disease respective causative pathogen disease causative pathogen acute anterior poliomyelitis polio virus ano-genital wart human papilloma virus anthrax bacillus anthracis bacillus cereus food-borne bacillus cereus infection intoxication bacterial meningitis (not otherwise specified) botulism clostridium botulinum brucellosis brucella specie campylobacter infection campylobacter specie carbapenemase producing enterobacteriaceae enterobacteriaceae infection colonisation chancroid haemophilus ducreyi 4 53 chickenpox - hospitalised case varicella-zoster virus chikungunya disease chikungunya virus chlamydia trachomatis infection chlamydia trachomatis (genital) cholera vibrio cholerae clostridium difficile infection clostridium difficile clostridium perfringens (type a) food- clostridium perfringens borne disease covid-19 sars-cov-2 creutzfeldt jakob disease variant creutzfeldt jakob disease cryptosporidiosis cryptosporidium parvum hominis cytomegalovirus infection (congenital) cytomegalovirus dengue fever dengue virus diphtheria corynebacterium diphtheriae ulcerans (toxin producing) echinococcosis echinococcus specie 53 5 enterococcal bacteraemia enterococcus specie (blood) escherichia coli infection (invasive) escherichia coli (blood csf) giardiasis giardia lamblia gonorrhoea neisseria gonorrhoeae granuloma inguinale klebsiella granulomatis haemophilus influenzae disease haemophilus influenzae (blood csf (invasive) normally sterile site) hepatitis (acute) infection hepatitis virus hepatitis b (acute chronic) hepatitis b virus infection hepatitis c infection hepatitis c virus hepatitis e infection hepatitis e virus herpes simplex (genital) herpes simplex virus herpes simplex (neonatal) herpes simplex virus human immunodeficiency virus human immunodeficiency virus infection influenza influenza b virus 6 53 klebsiella pneumoniae infection klebsiella pneumoniae (blood (invasive) csf) legionellosis legionella specie leprosy mycobacterium leprae leptospirosis leptospira specie listeriosis listeria monocytogenes lyme disease (neuroborreliosis) borrelia burgdorferi lymphogranuloma venereum chlamydia trachomatis malaria plasmodium falciparum vivax knowlesi ovale malariae mcr-positive enterobacteriaceae enterobacteriaceae infection colonisation measles measles virus meningococcal disease neisseria meningitidis mumps mumps virus non-specific urethritis novel rare antimicrobial-resistant 53 7 organism (nrao) noroviral infection norovirus paratyphoid salmonella paratyphi pertussis plague bordetella pertussis yersinia pestis pseudomonas aeruginosa infection pseudomonas aeruginosa (blood (invasive) csf) q fever rabies coxiella burnetii rabies virus respiratory syncytial virus infection respiratory syncytial virus rotavirus infection rotavirus rubella rubella virus salmonellosis salmonella spp s typhi s paratyphi severe acute respiratory syndrome sars-associated coronavirus (sars) shigellosis shigella specie 8 53 smallpox variola virus staphylococcal food poisoning enterotoxigenic staphylococcus aureus staphylococcus aureus bacteraemia staphylococcus aureus (blood) streptococcus group infection streptococcus pyogenes (blood csf (invasive) normally sterile site) streptococcus group b infection streptoccus agalactiae (blood csf (invasive) normally sterile site) streptococcus pneumoniae infection streptococcus pneumoniae (blood (invasive) csf normally sterile site) syphilis tetanus treponema pallidum clostridium tetani toxoplasmosis toxoplasma gondii trichinosis trichinella specie trichomoniasis trichomonas vaginalis tuberculosis mycobacterium tuberculosis complex tularemia francisella tularensis 53 9 typhoid typhus salmonella typhi rickettsia prowazekii verotoxigenic escherichia coli verotoxin producing escherichia coli infection viral encephalitis viral haemorrhagic fever viral meningitis west nile fever west nile virus yellow fever yellow fever virus yersiniosis yersinia enterocolitica yersinia pseudotuberculosis zika virus infection zika virus  10 53 given official seal minister health 20 february 2020 simon harris minister health 53 11", "start_char": 650, "end_char": 6313, "source_path": "downloads\\2020\\2020_0052.pdf", "extraction_method": "pdfminer", "checksum": "sha256:574aa40ab33f0e0cf695a6e57e8d9e4dd6916f4c1be730c0561708a21c1b93bf", "cross_refs": []}
{"doc_id": "si-2020-0053-explanatory-note", "parent_doc_id": "si-2020-0053", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 53 of 2020", "title": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are", "year": 2020, "heading": "(This note is not part of the Regulation and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Regulation and does not purport to be a legal \ninterpretation) \n\nThese Regulations (Regulation 3(d)) amend the Schedule to the Infectious \nDiseases Regulations 1981 (S.I. No. 390 of 1981) to include Covid-19 amongst \nthe list of diseases designated as an ‘infectious disease’ for the purposes of the \nHealth Act 1947, in accordance with Regulation 6 of those Regulations – all \ndiseases that are so designated are required to be notified (by a medical \npractitioner who becomes aware or suspects an instance of such disease) to a \nmedical officer of health and are subsequently relayed to the HSE’s Health \nProtection Surveillance Centre in accordance with Regulation 14 of the 1981 \nRegulations (as amended). \n\nThese Regulations (Regulation 3(a)) also amend Regulation 8 of the Infectious \nDiseases Regulations 1981 to provide for the inclusion of Covid-19 amongst \nthe list of infectious diseases that a person (who is a probable source of \ninfection with the disease) may (as a necessary safeguard against the spread of \nthe disease) be detained and isolated for, in accordance with the Health Act", "text_norm": "explanatory note (this note part regulation purport legal interpretation) regulation (regulation 3(d)) amend schedule infectious disease regulation 1981 (s.i no 390 1981) include covid-19 amongst list disease designated infectious disease purpose health act 1947 accordance regulation 6 regulation - disease designated required notified (by medical practitioner becomes aware suspect instance disease) medical officer health subsequently relayed hse health protection surveillance centre accordance regulation 14 1981 regulation (as amended) regulation (regulation 3(a)) also amend regulation 8 infectious disease regulation 1981 provide inclusion covid-19 amongst list infectious disease person (who probable source infection disease) may (as necessary safeguard spread disease) detained isolated accordance health act", "start_char": 6313, "end_char": 7464, "source_path": "downloads\\2020\\2020_0052.pdf", "extraction_method": "pdfminer", "checksum": "sha256:574aa40ab33f0e0cf695a6e57e8d9e4dd6916f4c1be730c0561708a21c1b93bf", "cross_refs": []}
{"doc_id": "si-2020-0053-reg-1947", "parent_doc_id": "si-2020-0053", "section_id": "reg-1947", "section_label": "Regulation 1947.", "si_number": "S.I. No. 53 of 2020", "title": "3. The Infectious Diseases Regulations 1981 (S.I. No. 390 of 1981) are", "year": 2020, "heading": "These Regulations (Regulations 3(b) and (c) also provide for the preliminary", "text_raw": "1947. \n\nThese Regulations (Regulations 3(b) and (c) also provide for the preliminary \nnotification (i.e. immediate notification by telephone) of Covid-19. \n\n \n \n \n \n \n \n \n \n \n\f12 [53] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-post: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.50 \n\n(DH-54) 75. 02/20. Propylon.", "text_norm": "1947 regulation (regulations 3(b) (c) also provide preliminary notification (i.e immediate notification telephone) covid-19 12 53 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-post publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur 3.50 (dh-54) 75 02 20 propylon", "start_char": 7464, "end_char": 8099, "source_path": "downloads\\2020\\2020_0052.pdf", "extraction_method": "pdfminer", "checksum": "sha256:574aa40ab33f0e0cf695a6e57e8d9e4dd6916f4c1be730c0561708a21c1b93bf", "cross_refs": []}
